An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab-Reference-Cited by-同舟云学术

An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab

Published:2012-03 Issue:3 Volume:50 Page:134-141
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Gasdaska John R.,Sherwood Steven,Regan Jeffrey T.,Dickey Lynn F.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference35 articles.

1. The potential utility of B cell-directed biologic therapy in autoimmune diseases;Arkfeld;Rheumatol. Int.,2008

2. Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation;Beers;Blood,2008

3. Monoclonal antibodies for B-cell lymphomas: rituximab and beyond;Bello;Hematol. Am. Soc. Hematol. Educ. Program,2007

4. Flow cytometric assay for determination of FcγRIIIA-158V/F polymorphism;Böttcher;J. Immunol. Methods,2005

5. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab;Bowles;Blood,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cells and generation of antibodies;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-Inflammatory Pathways;Current Pharmaceutical Biotechnology;2024-08-08

3. Homoeostatic Versus Pathogenic Autoantibodies: Origin, Structure and Effector Functions;Molecular Biology of B Cells;2024

4. The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy;Frontiers in Immunology;2023-07-27

5. Inhibiting N‐glycan processing increases the antibody binding affinity and effector function of human natural killer cells;Immunology;2023-05-22